Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

19.24

+0.93 (5.08%)

At close: Feb 26, 2026, 4:00 PM EST

22.00

+2.76 (14.35%)

After-hours: Feb 26, 2026, 4:48 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biotechnology	412.26M	306.13M	258.49M
Biotechnology Growth	34.67%	18.43%	-
Total	412.26M	306.13M	258.49M
Total Growth	34.67%	18.43%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	401.84M	293.41M	244.51M
United States Growth	36.95%	20.00%	-
International	10.42M	12.72M	13.98M
International Growth	-18.05%	-8.99%	-
Total	412.26M	306.13M	258.49M
Total Growth	34.67%	18.43%	-

Source: S&P Global Market Intelligence.